Day: June 2, 2020

VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) — Liberty Gold Corp. (LGD-TSX) (“Liberty Gold” or the “Company”) is pleased to announce the receipt of the initial option payments (the “Initial Option Payments”) under the definitive purchase option agreement (the “Agreement”) (see press release of May 4, 2020) for the sale of its 79.9% interest in the Kinsley Mountain gold deposit, a Carlin-style gold deposit in eastern in Nevada (“Kinsley”) to Barrian Mining Corp. (TSX-V: BARI)) (“Barrian”).Barrian has announced a change to its name and corresponding ticker symbol to New Placer Dome Gold Corp. (“New Placer Dome”) and TSX-V:NGLD, respectively, concurrently with making the Initial Option Payments to Liberty Gold.Pursuant to the terms of the Agreement, Liberty Gold has or will receive in total consideration for its interest...

CHICAGO, June 02, 2020 (GLOBE NEWSWIRE) — TransUnion (NYSE: TRU) today announced that Chris Cartwright, President and CEO, and Todd Cello, CFO, will present at the William Blair Growth Stock Conference on Tuesday, June 9, 2020. The presentation is scheduled to begin at 8:00 a.m. CST (9:00 a.m. EST). A live webcast of the presentation will be made available at the TransUnion Investor Relations website at http://www.transunion.com/tru. A replay will be available on the company’s website following the conclusion of the presentation.About TransUnion (NYSE: TRU)TransUnion is a global information and insights company that makes trust possible in the modern economy. We do this by providing a comprehensive picture of each person so they can be reliably and safely represented in the marketplace. As a result, businesses and consumers can...

SAN JOSE, Calif., June 02, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced the appointment of Mr. Jinqiu (Edwards) Tang as the Chief Financial Officer of the Company, effective June 1, 2020. Mr. Tang will succeed to Ms. Yu (Rain) Zhang, who resigned as the Chief Financial Officer of the Company for personal reasons effective on May 31, 2020.Mr. Jinqiu (Edwards) Tang has served as AnPac Bio’s Corporate Controller since October 2019. Prior to joining AnPac Bio, Mr. Tang served as a global internal auditor at Natuzzi S.p.A (Italy) from 2016 to 2019. Previously, he worked for Beijing Dongshen CPAs from 2013 to 2016 and Shanghai De’an CPAs...

CALGARY, Alberta, June 02, 2020 (GLOBE NEWSWIRE) — Shaw Communications Inc. (“Shaw”) will be releasing its consolidated results for the Third Quarter (ending May 31, 2020) on Friday, July 10, 2020 at 2:30 pm Mountain Time (4:30 pm Eastern Time)A conference call with Shaw Senior Management and the financial community is scheduled as follows. Press/Media and the public will be able to participate in listen-only mode.   Conference Call Details:Friday, July 10, 2020 at 3:30 pm Mountain Time; 5:30 pm Eastern TimePlease call 5 to 10 minutes before the start of the conference call.Replay Dial In: available until midnight Eastern Time, Friday, August 21, 2020Webcast:You can listen to the live or recorded broadcast at:http://services.choruscall.ca/links/shawq320200710.htmlThe webcast is available until midnight Eastern Time, Monday, August...

NEWMARKET, Ontario, June 02, 2020 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS) (the “Company” or “AirBoss”) today announced that it has appointed Mr. Frank Ientile to the role of Chief Financial Officer.“Frank brings broad experience in the diversified industrials space, in addition to specific expertise in the automotive and heavy transportation sectors, to his new role with AirBoss,” said Mr. Gren Schoch, Chairman and CEO of AirBoss of America Corp. “His three decades of financial management experience will be invaluable as we continue to work to grow each of our operating businesses and drive margins through a combination of strategies including new product introductions and continuous improvement initiatives.”Mr. Ientile has 30 years of progressively senior financial leadership experience, largely...

CAMBRIDGE, Mass., June 02, 2020 (GLOBE NEWSWIRE) — Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in fireside chats at two upcoming virtual investor conferences:  Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 3:00 p.m. E.T.BofA Securities Napa Biopharma Conference on Wednesday, June 24, 2020 at 12:30 p.m. E.T.The presentations will be webcast live under the investor relations section of Sarepta’s website at www.sarepta.com and will be archived there following the presentation for 90 days. Please connect to Sarepta’s website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.About Sarepta TherapeuticsAt Sarepta,...

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — The Board of Directors of Constellation Software Inc. (“Constellation”) (TSX: CSU) announced today the appointment of Donna Parr, Andrew Pastor, Barry Symons and John Billowits to Constellation’s Board of Directors.Donna Parr has significant experience in venture and private equity investing and corporate finance working for Canadian Medical Discoveries Fund, Ontario Municipal Employees Retirement System, Canada Pension Plan, and several other institutional investors.  Ms. Parr has served on 35 boards of private companies primarily on behalf of institutional investors and several as an Independent Corporate Director, including a term as a director of Constellation from 1995 to 2003.  Ms. Parr is currently the President of Crimson Capital, and a Director of the Centurion Financial Trust....

VANCOUVER, British Columbia, June 02, 2020 (GLOBE NEWSWIRE) — SHARC International Systems Inc. (CSE: SHRC) (FSE: IWIA) (OTCQB: INTWF) (“SHARC” or the “Company”) has previously announced on April 24, 2020 and May 15, 2020 that the Company will be relying on relief granted by the British Columbia Securities Commission (“BCSC”) under BC Instrument 51-525 (“BCI 51-525“) for temporary exemption from certain continuous disclosure requirements due to the challenges created by COVID-19. A copy of the temporary exemption granted by the BCSC in response to the COVID-19 Pandemic can be found here: BC Instrument 51-515.The Company expects to file the following annual filings by June 5, 2020:Audited Annual Financial Statements for the year ended December 31, 2019Management Discussion and Analysis for the year ended December...

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Wesdome Gold Mines Ltd. (TSX: WDO) (the “Company”) announces the results of the Company’s annual general meeting of shareholders (the “Meeting”) held by way of live webcast earlier today. A replay of the Meeting is available on the Company’s website.A total of 71,804,870 common shares were represented at the Meeting, representing 51.86% of the total issued and outstanding common shares of the Company.All matters presented for shareholder approval at the Meeting were approved, as follows:Election of DirectorsThe following seven individuals were elected as directors of the Company, until the next annual meeting of shareholders, as set out in the table below:Re-Appointment of AuditorsBased on proxies received and votes cast by show of hands during the Meeting, Grant Thornton LLP, Chartered...

LYON, France and CAMBRIDGE, Mass., June 02, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that Gil BEYEN, Chief Executive Officer, will be participating in a fireside chat at the Jefferies Virtual Healthcare Conference on June 4, 2020, at 08:30 am ET.Presentation Details:Event: Jefferies Virtual Healthcare Conference – Q&A sessionDate: Thursday, June 4, 2020Time: 08:30am to 08:55am ETAbout ERYTECH and eryaspaseERYTECH is a clinical-stage biopharmaceutical company developing innovative red blood cell-based therapeutics for severe forms of cancer and orphan diseases. Leveraging its proprietary ERYCAPS® platform, which uses a novel technology...